NAV
₹33.7542
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +8.33%
- 3Y
- +22.08%
- 5Y
- +11.97%
- Since Inception
- +18.14%
SIP returns (XIRR)
- 1Y
- +11.67%
- 3Y
- +14.59%
- 5Y
- +15.40%
- Since Inception
- +16.86%
Returns calculated from 28 February 2019 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Sectoral allocation
as of 30 Apr 2026Each sector links to the mutual funds most exposed to it.
Thinking about LIC MF Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with LIC MF Healthcare Fund-Regular Plan-Growth
- 1Sun Pharmaceutical Industries Ltd.11.22%
- 2Apollo Hospitals Enterprise Ltd.6.52%
- 3Torrent Pharmaceuticals Ltd.6.50%
- 4Aurobindo Pharma Ltd.5.15%
- 5Divi'S Laboratories Ltd.4.74%
- 6Fortis Healthcare Ltd.4.70%
- 7Neuland Laboratories Ltd.4.59%
- 8Onesource Specialty Pharma Ltd.4.56%
- 9Piramal Pharma Ltd.4.33%
- 10Glenmark Pharmaceuticals Ltd.3.41%
Investment Objective
LIC MF Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
LIC MF Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by LIC Mutual Fund. The fund has been operational for over 7 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations